Trials / Unknown
UnknownNCT00126802
The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer
The Role of Tomotherapy (Dynamic IMRT and Megavoltage CT Scanning) in Hypofractionated/Dose Escalated Conformal Radiation Treatment Using Magnetic Resonance Spectroscopy (MRS) Scans to Predict and Document the Pattern of Local Failure for High Risk Prostate Cancer
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- AHS Cancer Control Alberta · Academic / Other
- Sex
- Male
- Age
- 75 Years
- Healthy volunteers
- Not accepted
Summary
Helical tomotherapy is being used to treat the prostate gland, local rates of spread and regional lymph nodes whilst sparing gross structures. The radiation to the gross disease in the prostate is hypofractionated and dose escalated. Magnetic resonance spectroscopic imaging (MRSI) is incorporated into pre- and post-treatment evaluation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Tomotherapy | Standard 45 Gy in 25 fractions in 5 weeks |
Timeline
- Start date
- 2005-04-01
- Primary completion
- 2017-03-01
- Completion
- 2017-03-01
- First posted
- 2005-08-05
- Last updated
- 2016-07-06
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00126802. Inclusion in this directory is not an endorsement.